Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer

被引：0

作者：

Okamoto, W. ^{[1
]}

Nakamura, Y. ^{[2
]}

Shiozawa, M. ^{[3
]}

Komatsu, Y. ^{[4
]}

Denda, T. ^{[5
]}

Hara, H. ^{[6
]}

Kagawa, Y. ^{[7
]}

Narita, Y. ^{[8
]}

Kawakami, H. ^{[9
]}

Esaki, T. ^{[10
]}

Nishina, T. ^{[11
]}

Izawa, N. ^{[12
]}

Ando, K. ^{[13
]}

Moriwaki, T. ^{[14
]}

Kato, T. ^{[15
]}

Nagashima, F. ^{[16
]}

Satoh, T. ^{[17
]}

Nomura, S. ^{[18
]}

Yoshino, T. ^{[2
]}

Akagi, K. ^{[19
]}

机构：

[1] Hiroshima Univ Hosp, Canc Treatment Ctr, Hiroshima, Japan

[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[3] Kanagawa Canc Ctr, Gastrointestinal Surg, Yokohama, Kanagawa, Japan

[4] Hokkaido Univ Hosp, Dept Canc Chemotherapy, Canc Ctr, Sapporo, Hokkaido, Japan

[5] Chiba Canc Ctr Hosp, Div Gastroenterol, Chiba, Japan

[6] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan

[7] Kansai Rosai Hosp, Surg, Amagasaki, Hyogo, Japan

[8] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[9] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan

[10] Natl Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Fukuoka, Japan

[11] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan

[12] St Marianna Univ, Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan

[13] Kyushu Univ, Surg & Sci, Fukuoka, Fukuoka, Japan

[14] Univ Tsukuba, Gastroenterol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Osaka Natl Hosp, Dept Surg, Osaka, Japan

[16] Kyorin Univ Hosp, Med Oncol, Tokyo, Japan

[17] Osaka Univ, Fac Med, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan

[18] Natl Canc Ctr Hosp East, Clin Res Support Off, Kashiwa, Chiba, Japan

[19] Saitama Canc Ctr, Mol Diag & Canc Prevent, Saitama, Japan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

614P

引用

下载

页数：2

共 50 条

[1] Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer.
Okamoto, Wataru
Nakamura, Yoshiaki
Shiozawa, Manabu
Komatsu, Yoshito
Denda, Tadamichi
Hara, Hiroki
Kagawa, Yoshinori
Narita, Yukiya
Kawakami, Hisato
Esaki, Taito
Nishina, Tomohiro
Izawa, Naoki
Ando, Koji
Moriwaki, Toshikazu
Kato, Takeshi
Nagashima, Fumio
Satoh, Taroh
Nomura, Shogo
Yoshino, Takayuki
Akagi, Kiwamu
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[2] Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
Gallois, Claire
Landi, Matteo
Taieb, Julien
Sroussi, Marine
Saberzadeh-Ardestani, Bahar
Cazelles, Antoine
Lonardi, Sara
Bergamo, Francesca
Intini, Rossana
Maddalena, Giulia
Pietrantonio, Filippo
Corti, Francesca
Ambrosini, Margherita
Martinetti, Antonia
Germani, Marco Maria
Boccaccio, Chiara
Vetere, Guglielmo
Mouillet-Richard, Sophie
de Reynies, Aurelien
Sinicrope, Frank A.
Cremolini, Chiara
Laurent-Puig, Pierre
CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3771 - 3778
[3] Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors
Gallois, Claire
Landi, Matteo
Taieb, Julien
Lonardi, Sara
Bergamo, Francesca
Intini, Rossana
Maddalena, Giulia
Pietrantonio, Filippo
Corti, Francesca
Ambrosini, Margherita
Martinetti, Antonia
Germani, Marco Maria
Boccaccio, Chiara
Vetere, Guglielmo
Mouillet-Richard, Sophie
de Reynies, Aurelien
Puig, Pierre Laurent
Cremolini, Chiara
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[4] Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Schrock, A. B.
Ouyang, C.
Sandhu, J.
Sokol, E.
Jin, D.
Ross, J. S.
Miller, A.
Lim, D.
Amanam, I
Chao, J.
Catenacci, D.
Cho, M.
Braiteh, F.
Klempner, S. J.
Ali, S. M.
Fakih, M.
ANNALS OF ONCOLOGY, 2019, 30 (07) : 1096 - 1103
[5] Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
Borelli, Beatrice
Antoniotti, Carlotta
Carullo, Martina
Germani, Marco Maria
Conca, Veronica
Masi, Gianluca
CANCERS, 2022, 14 (20)
[6] Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
Bui, Quang Loc
Mas, Leo
Hollebecque, Antoine
Tougeron, David
de la Fouchardiere, Christelle
Pudlarz, Thomas
Alouani, Emily
Guimbaud, Rosine
Taieb, Julien
Andre, Thierry
Colle, Raphael
Cohen, Romain
CANCERS, 2022, 14 (02)
[7] Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy
Roth, Marc T.
Das, Satya
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (02) : 229 - 238
[8] Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Pietrantonio, Filippo
Lonardi, Sara
Corti, Francesca
Infante, Gabriele
Elez, Maria Elena
Fakih, Marwan
Jayachandran, Priya
Shah, Aakash Tushar
Salati, Massimiliano
Fenocchio, Elisabetta
Salvatore, Lisa
Curigliano, Giuseppe
Cremolini, Chiara
Ambrosini, Margherita
Ros, Javier
Intini, Rossana
Nappo, Floriana
Damian, Silvia
Morano, Federica
Fuca, Giovanni
Overman, Michael
Miceli, Rosalba
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
[9] The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer
Lee, Jong Yoon
KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 77 (05): : 261 - 262
[10] Overview of Microsatellite Instability and Immune Checkpoint Inhibitors in Colorectal Cancer
Kim, Dae Won
Lee, Jung-Hoon
Kim, Kunhwa
Imanirad, Iman
CURRENT COLORECTAL CANCER REPORTS, 2018, 14 (06) : 167 - 174

← 1 2 3 4 5 →